Loading insider details...
Beta
Latest Form 4 (Oct 1, 2026): Exercise/Conversion of 921 CNSY shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 1, 2026 | CERENOME, INC. (CNSY) | Exercise/Conversion | 921 | n/a |
| Jul 1, 2026 | PLUS THERAPEUTICS, INC. (PSTV) | Exercise/Conversion | 922 | n/a |
| May 18, 2026 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/Award | 3,686 | n/a |
| Aug 15, 2025 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/Award | 297,794 | n/a |
| Mar 6, 2023 | ATOSSA THERAPEUTICS, INC. (ATOS) | Grant/Award | 557,900 | n/a |
| Feb 28, 2022 | ATOSSA THERAPEUTICS, INC. (ATOS) | Grant/Award | 746,667 | n/a |
| May 18, 2021 | ATOSSA THERAPEUTICS, INC. (ATOS) | Grant/Award | 850,000 | n/a |
| Apr 13, 2020 | ATOSSA THERAPEUTICS, INC. (ATOS) | Grant/Award | 195,000 | n/a |